Hui-Li Wong

Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms reply

Matthew Loft, Hui-Li Wong, Peter Gibbs

Journal article  |  2021  |  INTERNAL MEDICINE JOURNAL

Experience of a dedicated carcinoma of unknown primary clinic in an Australian comprehensive cancer centre

Arielle van Mourik, Gina Tonkin-Hill, John O'Farrell, Lavinia Tan, Tharani Sivakumaran, Hui Li Wong, Linda Mileshkin

Conference Proceedings  |  2021  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Complete metabolic response following anaplastic lymphoma kinase (ALK) targeted therapy in a patient with adenocarcinoma of unknown primary with immunohistochemistry/fluorescence in situ hybridisation discordant ALK test results

Grace Chazan, Danielle Forbes, Anand Murugasu, Hui-Li Wong, Benjamin Solomon

Journal article  |  2021  |  INTERNAL MEDICINE JOURNAL

Real-world outcomes for neoadjuvant capecitabine versus infusional 5-fluorouracil in the treatment of locally advanced rectal cancer

Matthew Loft, Hui-Li Wong, Suzanne Kosmider, Margaret Lee, Jeanne Tie, Rachel Wong, Ian T Jones, Matthew Croxford, Malcolm Steel, Ian Faragher, Mario Guerrieri, Michael Christie, Peter Gibbs

Journal article  |  2021  |  INTERNAL MEDICINE JOURNAL

BACKGROUND: Neoadjuvant chemoradiation therapy is standard-of-care treatment for locally advanced rectal cancer (LARC). A patholog..

Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer

Lucy Gately, Azim Jalali, Christine Semira, Ian Faragher, Matthew Croxford, Sumitra Ananda, Suzanne Kosmider, Kathryn Field, Sheau Wen Lok, Grace Gard, Malcolm Steel, Margaret Lee, Rachel Wong, Hui-Li Wong, Peter Gibbs

Journal article  |  2021  |  ACTA ONCOLOGICA

BACKGROUND: Multiple meta-analyses have demonstrated that routine surveillance following colorectal cancer surgery improves surviv..

Feasibility of implementing a pharmacist-led DPYD gene testing service for patients commencing 5-fluorouracil (5FU) or capecitabine.

Benjamin Lee, Sarah Glewis, Marliese Alexander, Danny Rischin, Prudence A Francis, Michael Jefford, Hui-Li Wong, Jeanne Tie, Michael Michael, Senthil Lingaratnam

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

e18644 Background: Polymorphisms in the DPYD gene, which encodes for dihydropyrimidine dehydrogenase (DPD), may impair DPD metabo..

Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study

Jeanne Tie, Yuxuan Wang, Joshua Cohen, Lu Li, Wei Hong, Michael Christie, Hui Li Wong, Suzanne Kosmider, Rachel Wong, Benjamin Thomson, Julian Choi, Adrian Fox, Kathryn Field, Matthew Burge, Jenny Shannon, Dusan Kotasek, Niall C Tebbutt, Christos Karapetis, Craig Underhill, Andrew Haydon, et al.

Journal article  |  2021  |  PLOS MEDICINE

BACKGROUND: In patients with resectable colorectal liver metastases (CRLM), the role of pre- and postoperative systemic therapy co..

Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian population

Sandy Tun Min, Aflah Roohullah, Annette Tognela, Azim Jalali, Margaret Lee, Rachel Wong, Jeremy Shapiro, Matthew Burge, Desmond Yip, Louise Nott, Allan Zimet, Belinda Lee, Andrew Dean, Simone Steel, Hui-Li Wong, Peter Gibbs, Stephanie Hui-Su Lim

Journal article  |  2021  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

BACKGROUND: Colorectal cancer is the third most common cancer and second leading cause of cancer mortality in Australia, thus carr..

Immunohistochemical evaluation of the prognostic and predictive power of epidermal growth factor receptor ligand levels in patients with metastatic colorectal cancer

Siavash Foroughi, Ryan A Hutchinson, Hui-li Wong, Michael Christie, Ahida Batrouney, Rachel Wong, Margaret Lee, Jeanne Tie, Antony Wilks Burgess, Peter Gibbs

Journal article  |  2021  |  GROWTH FACTORS

For patients with metastatic colorectal cancer (mCRC), epidermal growth factor receptor (EGFR) inhibitors are limited to patients ..

Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status

Avraham Travers, Azim Jalali, Stephen Begbie, Christine Semira, Suzanne Kosmider, Sumitra Ananda, Rachel Wong, Margaret Lee, Jeremy Shapiro, Matthew Burge, Desmond Yip, Javier Torres, Brigette Ma, Louise Nott, Andrew Dean, Jeanne Tie, Adnan Khattak, Stephanie Lim, Hui-li Wong, Peter Gibbs

Journal article  |  2021  |  CLINICAL COLORECTAL CANCER

BACKGROUND: The management of metastatic colorectal cancer patients with a poor performance status (PS) continues to be a clinical..